<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel rdf:about="http://hdl.handle.net/123456789/255">
<title>Department of Pathology &amp; Microbiology</title>
<link>http://hdl.handle.net/123456789/255</link>
<description/>
<items>
<rdf:Seq>
<rdf:li rdf:resource="http://hdl.handle.net/123456789/20711"/>
<rdf:li rdf:resource="http://hdl.handle.net/123456789/20712"/>
<rdf:li rdf:resource="http://hdl.handle.net/123456789/20710"/>
<rdf:li rdf:resource="http://hdl.handle.net/123456789/18859"/>
</rdf:Seq>
</items>
<dc:date>2026-04-04T10:43:09Z</dc:date>
</channel>
<item rdf:about="http://hdl.handle.net/123456789/20711">
<title>DIFFERENTIAL EXPRESSION OF LGR5 AND  ITS DIAGNOSTIC SIGNIFICANCE IN  NEOPLASTIC AND NON –NEOPLASTIC  COLORECTAL LESIONS</title>
<link>http://hdl.handle.net/123456789/20711</link>
<description>DIFFERENTIAL EXPRESSION OF LGR5 AND  ITS DIAGNOSTIC SIGNIFICANCE IN  NEOPLASTIC AND NON –NEOPLASTIC  COLORECTAL LESIONS
DR MARVI ZIA  (06-114232-003)
Cancer stem cells (CSCs) play a major role in development, progression and in &#13;
aggressive chemo-resistant behavior as they provide a continuous pool for clonal &#13;
proliferation of malignant cells. LGR5, one of the most important stem cell marker is &#13;
implicated very early in metamorphosis of malignant transformation. LGR5 is directly &#13;
involved in cell proliferation through its effects on Wnt- β catenin pathway. In this cross- &#13;
sectional study we used 109 formalin fixed paraffin embedded (FFPE) tissue samples &#13;
and evaluated immuno-reactive score (IRS) of LGR5 expression in normal colonic &#13;
mucosa, adenomas and colorectal cancer tissue samples. Association between LGR5 &#13;
expression and various clinico-pathological parameters including grade, stage and &#13;
lymph-node metastasis was assessed .The comparison of mean LGR5 IRS scores across &#13;
non-neoplastic tissue, adenomas, and carcinomas was done . A binary logistic regression &#13;
was performed to examine the association of LGR5 expression (high vs. low) with &#13;
lesion type, T stage, N stage, and histological grade. Results: Histological type and &#13;
tumour grade significantly influence LGR5 expression. Conventional Adenocarcinomas &#13;
and well differentiated Grade 1 tumours exhibited strong LGR5 expression followed &#13;
by moderately differentiated (Grade 2) tumors, as compared to mucinous and signet ring &#13;
cell variants and poorly differentiated tumours Grade 3(p &lt;0.001). There was a &#13;
statistically significant difference in mean IRS scores among the three groups (p &lt; &#13;
0.001). The highest mean IRS score was observed in adenomas (mean = 9.42 ± 3.06), &#13;
followed by carcinomas (6.12 ± 3.62), whereas non-neoplastic tissues exhibited the &#13;
lowest mean IRS score (2.15 ± 2.02). The patients with Non-Neoplastic Lesions were &#13;
less likely to have high LGR5 expression (OR=0.077, p&lt;0.001) in comparison to &#13;
patients with neoplastic lesions. The study identified higher IRS score for LGR5 &#13;
expression in colorectal cancers and adenoma as compared to normal mucosa, thus &#13;
identifying it as a marker of neoplastic transformation. Increased LGR5 expression in &#13;
adenomas and grade 1 CRC identified this stem cell marker as a significant diagnostic &#13;
marker useful for early neoplastic lesion. Decline of LGR5 expression in poorly &#13;
differentiated tumours verified it as a marker of poor prognosis.
Supervised by Prof. Dr. Sumayyah Shawana
</description>
<dc:date>2025-12-01T00:00:00Z</dc:date>
</item>
<item rdf:about="http://hdl.handle.net/123456789/20712">
<title>IDENTIFICATION OF BRCA1 VARIANTS RS2053936273 AND  RS80357670 IN TRIPLE NEGATIVE BREAST CANCER (TNBC) IN  THE PAKISTANI POPULATION AT A TERTIARY CARE  HOSPITAL IN KARACHI: A SANGER SEQUENCING STUDY</title>
<link>http://hdl.handle.net/123456789/20712</link>
<description>IDENTIFICATION OF BRCA1 VARIANTS RS2053936273 AND  RS80357670 IN TRIPLE NEGATIVE BREAST CANCER (TNBC) IN  THE PAKISTANI POPULATION AT A TERTIARY CARE  HOSPITAL IN KARACHI: A SANGER SEQUENCING STUDY
DR HIRA SHOAIB  (06-114232-001)
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast carcinoma &#13;
characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and &#13;
HER2 expression, commonly associated with germline Breast cancer Gene 1 (BRCA1) &#13;
mutations. These mutations compromise homologous recombination DNA repair and &#13;
increase cancer susceptibility. Despite the high burden of Triple Negative Breast Cancer &#13;
in Pakistan, limited genetic data exists on the distribution of BRCA1 variants. Two &#13;
BRCA1 variants, rs2053936273 and rs80357670, have been reported in major Pakistani &#13;
studies as pathogenic frameshift mutations leading to truncated protein products; &#13;
however, their prevalence and clinical relevance in remains unclear. The present study &#13;
aimed to detect these BRCA1 variants in Triple Negative Breast cancer patients and &#13;
assess their correlation with clinico-pathological parameters. &#13;
A cross-sectional study was conducted at Pakistan Navy Station Shifa Hospital in Karachi &#13;
from November 2024 to October 2025. Fifty female Triple Negative Breast Cancer &#13;
patients aged 28–60 years were enrolled after biopsy and immunohistochemical &#13;
confirmation. Genomic DNA was extracted using Qiagen® kits, and Polymerase chain &#13;
reaction (PCR) amplification was performed at Ziauddin Medical University, Karachi. &#13;
Sanger sequencing was outsourced to Eurofins, United States of America. Sequence &#13;
alignment and variant annotation were performed using Molecular Evolutionary Genetic &#13;
Analysis (MEGA X), BioEdit, and Database Single Nucleotide Polymorphism (dbSNP). &#13;
Descriptive and associative statistics were analyzed using SPSS v23. &#13;
Of 50 samples, 39 yielded high-quality sequences suitable for variant analysis. Neither &#13;
rs2053936273 nor rs80357670 was detected in the study participants. However, two &#13;
variants of uncertain significance (VUS) were observed in 5.1% of samples. The majority &#13;
of cases occurred in patients under 50 years, with a subset showing a positive family &#13;
history. The absence of the targeted BRCA1 variants suggests potential ethnic specificity &#13;
and highlights the need for expanded genomic studies in the Pakistani TNBC population. &#13;
VIII &#13;
In conclusion, the findings emphasize the importance of population-based BRCA1 &#13;
variant profiling to develop localized genetic testing panels and inform early detection, &#13;
prevention, and counseling strategies for hereditary breast cancer in Pakistan.
Supervised by Prof. Dr. Summayyah Shawana
</description>
<dc:date>2025-11-01T00:00:00Z</dc:date>
</item>
<item rdf:about="http://hdl.handle.net/123456789/20710">
<title>ANTIBIOFILM FORMING ACTIVITY OF NATURAL  PRODUCTS AND PROBIOTIC AGAINST  STAPHYLOCOCCUS AUREUS AND  STREPTOCOCCUS PYOGENES  BIOFILM</title>
<link>http://hdl.handle.net/123456789/20710</link>
<description>ANTIBIOFILM FORMING ACTIVITY OF NATURAL  PRODUCTS AND PROBIOTIC AGAINST  STAPHYLOCOCCUS AUREUS AND  STREPTOCOCCUS PYOGENES  BIOFILM
DR. MUHAMMAD MOHSIN SAEED  (06-114212-003)
Staphylococcus aureus and Streptococcus pyogenes are part of normal flora of human &#13;
body. Both of them can form a biofilm. Biofilm is described as an adhered collection of &#13;
immobile groups of microbes fenced within extracellular polymeric substance (EPS). &#13;
Biofilm will provide microbes safe shelter and ideal environment for maximum growth &#13;
even under unfavorable conditions like extreme temperature, dehydration and radiations. &#13;
Biofilm associated infection of both microbes are becoming life-threatening problem due &#13;
to emerging antibiotic resistance, which necessitates discovery of new alternatives. Many &#13;
probiotics and natural products have advantageous anti-biofilm properties. Objectives of &#13;
the study were to assess the biofilm forming activity of Staphylococcus aureus and &#13;
Streptococcus pyogenes, to evaluate the anti-biofilm role of natural products i.e. Allium &#13;
cepa (Onion), Mentha piperita (mint) and Zingiber officinale (ginger) and also evaluate &#13;
the anti-biofilm activity of Probiotics (Lactobacillus). Another objective was to assess the &#13;
synergistic action of natural product and probiotics against biofilm formation. It is a &#13;
cross-sectional study. The samples collection is from different labs. The sample size is of &#13;
246 participants that belong to 1 - 75 years of age. Informed consent from patients taken. &#13;
Specimens were inoculated in lab on culture plates, and put for incubation at 37 °C for 24 &#13;
to 48 hours. Staphylococcus aureus and Streptococcus pyogenes are identified on the &#13;
basis of colony morphology, gram staining and biochemical test. Post identification ally &#13;
we use micro-titer plate assay for observing biofilm producing action of Staphylococcus &#13;
aureus and Streptococcus pyogenes. Then we employ natural product and probiotics on &#13;
these biofilms and observe the anti-biofilm potential by performing 96 well Plate &#13;
methods for biofilm assessment. 3 plant {Allium cepa (Onion), Mentha piperita (mint) &#13;
and (ginger) Zingiber officinale} and probiotic (Lactobacilli acidophilus) possess anti&#13;
biofilm activity individually and in combination. This anti-biofilm capability is further &#13;
enhanced when natural products and probiotics used in combination because they act &#13;
synergistically.
Supervised by Prof,Dr.Naveed Faraz
</description>
<dc:date>2025-11-01T00:00:00Z</dc:date>
</item>
<item rdf:about="http://hdl.handle.net/123456789/18859">
<title>P16 AND TOP2A IMMUNOHISTOCHEMICAL EXPRESSION FOR DETECTION OF CERVICAL INTRAEPITHELIAL AND EARLY MALIGNANT LESIONS</title>
<link>http://hdl.handle.net/123456789/18859</link>
<description>P16 AND TOP2A IMMUNOHISTOCHEMICAL EXPRESSION FOR DETECTION OF CERVICAL INTRAEPITHELIAL AND EARLY MALIGNANT LESIONS
DR. ARIBA NASREEN  06-114222-001
Cervical Cancer (CC) is the fourth most common type of cancer worldwide. In &#13;
vast majority of cases, it is caused by Human Papillomavirus (HPV) - a Sexually &#13;
Transmitted Disease (STD). In Pakistan, the incidence of cervical cancer is 4.9% while &#13;
its morbidity and mortality rates are considerably higher due to ignorance in terms of &#13;
screening, prevention and vaccination. As a result more than 70% women with CC are &#13;
diagnosed at very advanced stage of malignancy. In this time of vaccines, systematic &#13;
screening for CC may be considered as one of the most valuable tools for reducing the &#13;
disease burden and death rates. Despite the characteristic advantages of Liquid Based &#13;
Cytology (LBC) in cervical screening, LBC has low sensitivity (40-50%) which usually &#13;
leads to under diagnosis. While HPV testing in cervical screening has been proven &#13;
effective to some extent but its low specificity may result in unnecessary treatment and &#13;
high-risk HPV testing alone cannot differentiate between transient and persistent &#13;
infections. Hence, applying different markers in CC screening is necessary for its control, &#13;
early-diagnosis and prevention. P16 is a cyclin-dependant kinase inhibitor and plays a &#13;
crucial role as a cell cycle regulator by decelerating cell progression from G1 to S phase. &#13;
While Topoisomerase IIA is an enzyme responsible for DNA strands uncoupling during &#13;
its replication and expressed only in cycling cells. The primary objective of this study &#13;
was to assess immunohistochemical expression of P16 and TOP2A in normal, pre cancerous and cancerous cervical cytology cell blocks and to correlate their expression &#13;
level with cytological and various clinicopathological parameters. It was a cross-sectional &#13;
study conducted at PNS Shifa Hospital Karachi and Dr. Ruth K. M. Pfau, Civil Hospital, &#13;
Karachi over a time period of eight months. A total of 60 cervical cytology samples were &#13;
analyzed for immunohistochemical staining using CDKN2A/P16-INK4a Mouse (IgG) &#13;
and Topoisomerase II alpha Rabbit (IgG) Monoclonal antibodies. Demographic data and &#13;
various clinicopathological parameters were recorded using the designed Performa and &#13;
the results of immunostaining were analyzed and correlated with the documented &#13;
parameters. The results revealed that there is a significant association of P16 &#13;
immunohistochemical expression with age group, ethnicity, menopausal status, &#13;
cytological diagnosis, and cancer status. While TOP2A was only associated with &#13;
menopausal status, cytological diagnosis, and cancer status of the patients. P16 &#13;
ix &#13;
immunostaining was directly related with the increasing severity of cervical cytological &#13;
abnormalities. The sensitivity and specificity of P16 for detecting pre-cancerous and &#13;
cancerous lesion was significantly higher, whereas TOP2A demonstrated higher &#13;
specificity for detecting cancerous lesions. Therefore, P16 can be a reliable &#13;
immunohistochemical marker for diagnosing early as well as late cancerous lesion while &#13;
TOP2A is highly specific marker for ruling out non-cancerous lesion
Supervised by Prof. Dr. Summayya Shawana
</description>
<dc:date>2024-10-01T00:00:00Z</dc:date>
</item>
</rdf:RDF>
